May 16, 2026

As you approach your 2026 health insurance renewals, you are likely facing a landscape that looks drastically different from just two years ago. The rapid rise of Glucagon-Like Peptide-1 (GLP-1) medications: like Wegovy, Zepbound, and their successors: has moved from a pharmaceutical trend to a fundamental shift in how we design employee benefit packages. For […]

As you approach your 2026 health insurance renewals, you are likely facing a landscape that looks drastically different from just two years ago. The rapid rise of Glucagon-Like Peptide-1 (GLP-1) medications: like Wegovy, Zepbound, and their successors: has moved from a pharmaceutical trend to a fundamental shift in how we design employee benefit packages. For